Viatris VTRS is selling at a bargain ( for a Blue Chip Pharma ) under 0.9 Price to Book and started to pay a 2.85pct dividend which will grow. It is the new name for the merger of Mylan labs and Pfizer’s UpJohn division.

Here is the video recording of today’s company presentation to Goldman Sachs

And may be you or your family has used one or more of it products ?

Rated 4 stars by MorningStar Premium with a target price of $25.

submitted by /u/Pietro405
[link] [comments]

Go to Source of this post
Author Of this post: /u/Pietro405
Title Of post: Viatris VTRS Probably the most undervalued under the radar blue chip Pharma with 3pct div
Author Link: {authorlink}

By admin